| IRGSX | MGLCX | IRGSX / MGLCX | |
| Total Expense Ratio | 1.30 | 1.94 | 67% |
| Annual Report Gross Expense Ratio | 1.46 | 1.95 | 75% |
| Fund Existence | 20 years | 11 years | - |
| Gain YTD | 6.825 | 0.870 | 785% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 133M | 2.21B | 6% |
| Annual Yield % from dividends | 2.36 | 1.28 | 184% |
| Returns for 1 year | 6.19 | 0.19 | 3,346% |
| Returns for 3 years | 18.92 | 7.00 | 270% |
| Returns for 5 years | 13.60 | -5.01 | -271% |
| Returns for 10 years | 18.68 | 14.69 | 127% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| REEIX | 17.06 | 0.12 | +0.71% |
| RBC Emerging Markets Equity I | |||
| RAPCX | 11.10 | 0.04 | +0.36% |
| Cohen & Steers Real Assets C | |||
| SVOAX | 13.32 | N/A | N/A |
| SEI US Managed Volatility F (SIMT) | |||
| VSFCX | 22.40 | -0.06 | -0.27% |
| Federated Hermes MDT Small Cap Value C | |||
| PHPSX | 29.67 | -0.13 | -0.44% |
| ProFunds Pharmaceuticals UltraSector Svc | |||